Multivitamins/multiminerals in Switzerland: a first assessment The fallacy of slimming products: a case analysis in Switzerland by DROZ, N.
	  	   1	  
	  	   	   	   	   	   	   	  	   	  	  Master’s	  degree	  in	  Medicine	  no	  1466	  	  
Multivitamins/multiminerals	  in	  Switzerland:	  a	  
first	  assessment	  
The	  fallacy	  of	  slimming	  products:	  a	  case	  analysis	  
in	  Switzerland	  
Nadège	  Droz	  	  	  
Tutor	  :	  	   Pedro	  Marques-­‐Vidal	  MD,	  PhD	  Institute	  of	  Social	  and	  Preventive	  Medicine	  (IUMSP)	  
Expert	  :	   Dresse	  Jardena	  Puder,	  Médecin	  adjointe	  PD,	  MER	  Endocrinologie,	  CHUV	  	  	  Lausanne	  2013-­‐2014	  
	  	  
2	  
	  	  	  	  	  	  	  	  	  	  	  Ce	  travail	  comporte	  deux	  thèmes	  qui	  ont	  tous	  deux	  été	  acceptés	  dans	  les	  congrès	  suivants	  :	  	  Nutrition	  2013	  (Zürich,	  Suisse,	  6-­‐8	  Juin	  2013)	  Multivitamins/multiminerals	  in	  Switzerland:	  a	  first	  assessment	  ,	  N.Droz*,	  P.Marques-­‐Vidal	  (Lausanne,	  Suisse)	  –	  Poster	  The	  fallacy	  of	  slimming	  product:	  a	  case	  analysis	  in	  Switzerland,	  N.Droz*,	  P.	  Marques-­‐Vidal,	  (Lausanne,	  Suisse)	  –	  Poster	  	  Assemblée	  annuelle	  2013	  de	  la	  Société	  Suisse	  d’Endocrinologie	  et	  de	  Diabétologie	  (SSED)	  (Berne,	  Suisse,	  14	  Novembre	  2013)	  The	  fallacy	  of	  slimming	  product:	  a	  case	  analysis	  in	  Switzerland,	  N.Droz*,	  P.	  Marques-­‐Vidal,	  (Lausanne,	  Suisse)	  –	  Poster	  




Table	  des	  matières	  






REFERENCES ......................................................................................................................................... 18	  
THE	  FALLACY	  OF	  SLIMMING	  PRODUCTS:	  A	  CASE	  ANALYSIS	  IN	  SWITZERLAND ..................... 20	  
ABSTRACT ............................................................................................................................................. 20	  
INTRODUCTION ................................................................................................................................... 21	  
METHODS............................................................................................................................................... 21	  
RESULTS ................................................................................................................................................. 23	  
DISCUSSION........................................................................................................................................... 24	  
REFERENCES ......................................................................................................................................... 26	  	  
Liste	  des	  tableaux	  
Table	  1.	  Characteristics	  of,	  and	  vitamin/mineral	  provision	  by	  multivitamin-­‐multimineral	  supplements	  available	  in	  Switzerland. ...................................................................9	  
Table	  2:	  Characteristics	  of,	  and	  vitamin/mineral	  provision	  by	  multivitamin-­‐multimineral	  supplements	  available	  in	  Switzerland. ................................................................ 11	  
Table	  3.	  Comparison	  of	  the	  recommended	  dietary	  allowances	  for	  adults	  from	  the	  Swiss	  legislation	  and	  from	  the	  Swiss	  Society	  of	  Nutrition.................................................................... 16	  	  
	  	   5	  
Multivitamins/multiminerals	  in	  Switzerland:	  a	  first	  assessment	  
Abstract	  
Purpose:	   To	   assess	   the	   composition	   and	   compliance	   with	   legislation	   of	  multivitamin/multiminerals	  (MVM)	  in	  Switzerland.	  
Methods:	  Information	  on	  the	  composition	  of	  vitamin/minerals	  supplements	  was	  obtained	  from	  the	  Swiss	  drug	  compendium,	  the	  Internet,	  pharmacies,	  parapharmacies	  and	  supermarkets.	  MVM	  was	  defined	  as	  the	  presence	  of	  at	  least	  5	  vitamins	  and/or	  minerals.	  
Results:	  95	  MVM	  were	  considered.	  The	  most	  frequent	  vitamins	  were	  B6	  (73.7%),	  C	  (71.6%),	  B2	  (69.5%)	  and	  B1	  (67.4%);	  the	  least	  frequent	  were	  K	  (17.9%),	  biotin	  (51.6%),	  pantothene	  (55.8%)	  and	  E	  (56.8%).	  Around	  half	  of	  MVMs	  provided	  >150%	  of	  the	  ADI	  for	  vitamins.	  The	  most	  frequent	  minerals	  were	  zinc	  (66.3%),	  calcium	  (55.8%),	  magnesium	  (54.7%)	  and	  copper	  (48.4%),	  and	  the	  least	   frequent	  were	   fluoride	   (3.2%),	   phosphorous	   (17.9%)	   and	   chrome	   (22.1%).	  Only	   25%	  of	  MVMs	  contained	  iodine.	  More	  than	  two	  thirds	  of	  MVMs	  provided	  between	  15	  and	  150%	  of	  the	  ADI	  for	  minerals,	  and	  few	  MVMs	  provided	  >150%	  of	  the	  ADI.	  While	  few	  MVMs	  provided	  <15%	  of	  the	  ADI	  for	  vitamins,	  a	  considerable	  fraction	  did	  so	  for	  minerals	  (32.7%	  for	  magnesium,	  26.1%	  for	  copper	  and	  22.6%	  for	  calcium).	  
Conclusion:	   There	   is	   a	   great	   variability	   regarding	   the	   composition	   and	   amount	   of	   MVMs	   in	  Switzerland.	  Several	  MVM	  do	  not	  comply	  with	  the	  Swiss	  legislation.	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Introduction	  Consumption	   of	  multivitamin	   /	  mineral	   (MVM)	   supplements	   is	   popular	   in	   the	   general	  population	  [1,	  2],	  leading	  to	  a	  significant	  part	  of	  the	  overall	  dietary	  intake	  [3,	  4].	  In	  the	  European	  Union	  (EU),	  MVM	  represent	  half	  of	  the	  EU	  food	  supplement	  market,	  which	  has	  been	  estimated	  at	  around	   five	  billion	  Euros	   in	  2005	   [5].	  MVM	  can	  contain	  a	  variable	  number	  of	  vitamins	  and	  minerals,	   the	   characteristics	   and	   amounts	   ranges	   of	  which	   are	   regulated	   [6,	   7].	   Nevertheless,	  this	   legislation	   is	   relatively	   supple,	   as	   no	   definition	   of	   MVM	   is	   currently	   available,	   and	   the	  amounts	  of	  vitamins	  or	  minerals	  allowed	  per	  unit	   (pill,	   capsule...)	   can	  vary	  considerably.	  This	  leads	  to	  a	  large	  variety	  of	  MVM	  supplements	  available,	  which	  differ	  in	  the	  number	  and	  amount	  of	  vitamins	  and	  minerals	  included.	  Hence,	  shifting	  from	  one	  MVM	  supplement	  to	  another	  might	  lead	   to	   changes	   in	   the	  number	  and	  amount	  of	  vitamins	  and	  minerals	   consumed.	  Finally,	   from	  our	   own	   experience,	   many	   subjects	   are	   unable	   to	   remember	   the	   brand	   of	   the	   MVM	   they	  consume	  and	  many	  also	  believe	  that	  all	  MVMs	  are	  equivalent.	  
In	   this	   study,	   we	   aimed	   at	   characterizing	   the	   composition	   and	   compliance	  with	   Swiss	  legislation	  of	  the	  MVM	  available	  in	  Switzerland.	  
Methods	  	  The	  composition	  of	  vitamin/mineral	  supplements	  available	  in	  Switzerland	  was	  obtained	  from	   several	   sources:	   the	   Swiss	  drug	   compendium,	   the	   Internet,	   pharmacies,	   parapharmacies	  and	   supermarkets.	  Whenever	   necessary,	   further	   information	  was	   gathered	   by	   contacting	   the	  producer.	  The	  geographical	  search	  area	  was	  restricted	  to	  the	  Vaud	  canton,	  but	  all	  information	  in	  French,	   German	   or	   Italian	   (official	   languages	   in	   Switzerland)	   was	   collected.	   The	   following	  inclusion	  criteria	  were	  used:	  1)	  containing	  at	  least	  one	  vitamin	  /	  mineral;	  2)	  taken	  orally	  and	  3)	  amount	  of	  vitamin	  /	  mineral	  indicated.	  The	  second	  criterion	  led	  to	  the	  exclusion	  of	  intravenous	  or	   intramuscular	   preparations,	   while	   last	   criterion	   precluded	   the	   collection	   of	   supplements	  
	  	   7	  
such	  as	  “vitamin-­‐rich”	  herbal	  extracts	  or	   juices,	   for	  which	  no	  objective	  information	  on	  vitamin	  content	  was	  available.	  
For	   each	   vitamin/mineral	   supplement	   retained,	   the	   composition	   and	   the	   maximal	  recommended	   posology	   (if	   available)	   were	   collected.	   When	   the	   recommended	   posology	   was	  missing,	   the	   value	   of	   one	   unit/day	   was	   used.	   The	   percentage	   of	   the	   recommended	   dietary	  allowance	   (RDA)	   provided	   by	   the	  maximum	  posology	  was	   also	   calculated	   and	   categorized	   as	  follows:	   <15%,	   15-­‐150%	   and	   >150%.	   The	   RDAs	  were	   derived	   from	   the	   Swiss	   legislation	   [6].	  According	  to	  the	  Swiss	  legislation,	  if	  a	  MVM	  contains	  a	  vitamin	  (mineral)	  in	  amounts	  lower	  than	  15%	  or	  the	  RDA,	  this	  vitamin	  (mineral)	  should	  not	  be	  indicated	  on	  the	  label	  [6].	  No	  institutional	  ethical	  committee	  approval	  was	  needed	  as	  this	  study	  only	  focused	  on	  MVM.	  
Statistical	   analyses	   were	   conducted	   using	   Stata	   v.12	   (Stata	   corp,	   College	   Station,	   TX,	  USA).	   Descriptive	   results	   were	   presented	   as	   number	   (percentage)	   or	   median	   [interquartile	  range].	   As	   there	   is	   no	   common	   definition	   for	   a	  multivitamin	   preparation,	   two	   analyses	  were	  performed:	  the	   first	  considered	  all	  supplements	  with	  at	   least	  5	  vitamins	  and/or	  minerals,	  and	  the	  second	  included	  only	  supplements	  with	  at	  least	  10	  vitamins	  and/or	  minerals.	  
Results	  Of	   the	   254	   vitamin/mineral	   supplements	   initially	   retained,	   95	   (37%)	   had	   at	   least	   5	  components	   and	  were	   considered	   as	  MVM.	  Their	   composition	   is	   summarized	   in	   table	  1.	   The	  most	  frequent	  vitamins	  were	  B6,	  C,	  B2	  and	  B1,	  while	  vitamins	  K	  and	  A	  were	  present	  in	  less	  than	  half	  of	  the	  MVMs.	  The	  most	  frequent	  minerals	  were	  zinc,	  calcium,	  magnesium	  and	  copper,	  while	  iodine,	  fluoride,	  phosphorous,	  potassium	  and	  chrome	  were	  present	  in	  less	  than	  one	  quarter	  of	  the	   MVMs.	   When	   the	   maximum	   recommend	   posology	   was	   considered,	   almost	   half	   of	   the	  resulting	  intakes	  for	  vitamins	  were	  over	  150%	  of	  the	  RDA,	  although	  this	  percentage	  was	  lower	  for	  niacin	  and	  vitamin	  K	  (table	  1).	  Most	  of	  the	  resulting	  intakes	  for	  minerals	  were	  between	  15%	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and	  150%	  of	  the	  RDA,	  although	  higher	  percentages	  of	  MVMs	  below	  15%	  of	  RDA	  were	  noted	  for	  phosphorous,	  magnesium,	  copper	  and	  calcium	  (table	  1).	  
Restricting	   the	   analysis	   to	  MVM	  with	   at	   least	   10	   ingredients	   decreased	   the	   number	   of	  supplements	   to	   46	   (18%)	   and	   led	   to	   a	   slight	   decrease	   of	   the	   intakes	   representing	  more	   than	  150%	  of	  the	  RDA	  for	  vitamins,	  while	  no	  considerable	  change	  was	  found	  for	  minerals	  (table	  2).	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Table	  1.	  Characteristics	  of,	  and	  vitamin/mineral	  provision	  by	  multivitamin-­‐multimineral	  supplements	  available	  in	  Switzerland.	  




%	  RDA	  §	  
Median	  [IQR]	  
<15%	  RDA	   15-­150%	  
RDA	  
>150%	  RDA	  
Vitamins	   	   	   	   	   	   	  Vitamin	  A	  (IE)	   34	  (35.8)	   2667	  [1047	  -­‐	  3500]	   100	  [32.5	  -­‐	  131.2]	   4	  (11.8)	   30	  (88.2)	   -­‐	  Vitamin	  B1	  (mg)	   64	  (67.4)	   2.3	  [1.4	  -­‐	  4.5]	   205	  [127	  -­‐	  409]	   -­‐	   30	  (46.9)	   34	  (53.1)	  Vitamin	  B12	  (µg)	   58	  (61.0)	   4.5	  [2.5	  -­‐	  10]	   180	  [100	  -­‐	  400]	   -­‐	   26	  (44.8)	   32	  (55.2)	  Vitamin	  B2	  (mg)	   66	  (69.5)	   2.2	  [1.6	  -­‐	  4.8]	   157	  [114	  -­‐	  343]	   -­‐	   33	  (50.0)	   33	  (50.0)	  Vitamin	  B6	  (mg)	   70	  (73.7)	   3	  [2	  -­‐	  6]	   214	  [143	  -­‐	  429]	   -­‐	   27	  (38.6)	   43	  (61.4)	  Vitamin	  C	  (mg)	   68	  (71.6)	   100	  [60	  -­‐	  240]	   125	  [75	  -­‐	  300]	   2	  (2.9)	   37	  (54.3)	   29	  (42.7)	  Vitamin	  D	  (µg)	   57	  (60.0)	   10	  [5	  -­‐	  15]	   200	  [100	  -­‐	  300]	   -­‐	   25	  (43.9)	   32	  (56.1)	  Vitamin	  E	  (mg)	   54	  (56.8)	   17.5	  [10	  -­‐	  50]	   146	  [83	  -­‐	  417]	   -­‐	   27	  (50.0)	   27	  (50.0)	  Vitamin	  K	  (µg)	   17	  (17.9)	   50	  [27.5	  -­‐	  100]	   67	  [37	  -­‐	  133]	   -­‐	   14	  (82.3)	   3	  (17.7)	  Niacin	  (mg)	   61	  (64.2)	   20	  [17	  -­‐	  47]	   125	  [106	  -­‐	  294]	   -­‐	   37	  (60.7)	   24	  (39.3)	  Pantothenic	  acid	  (mg)	   53	  (55.8)	   16.2	  [6	  -­‐	  23.5]	   269	  [100	  -­‐	  392]	   -­‐	   18	  (34.0)	   35	  (66.0)	  Folic	  acid	  (µg)	   56	  (59.0)	   400	  [200	  -­‐	  600]	   200	  [100	  -­‐	  300]	   1	  (1.8)	   19	  (33.9)	   36	  (64.3)	  Biotin	  (µg)	   49	  (51.6)	   150	  [47.5	  -­‐	  200]	   300	  [95	  -­‐	  400]	   1	  (2.0)	   20	  (40.8)	   28	  (57.2)	  
Minerals	   	   	   	   	   	   	  Calcium	  (mg)	   53	  (55.8)	   200	  [122.5	  -­‐	  500]	   25	  [15	  -­‐	  63]	   12	  (22.6)	   37	  (69.8)	   4	  (7.6)	  Magnesium	  (mg)	   52	  (54.7)	   100	  [50	  -­‐	  187.5]	   27	  [13	  -­‐	  50]	   17	  (32.7)	   33	  (63.5)	   2	  (3.9)	  Iron	  (mg)	   39	  (41.1)	   10	  [5.6	  -­‐	  14]	   71	  [40	  -­‐	  100]	   4	  (10.3)	   30	  (76.9)	   5	  (12.8)	  Copper	  (µg)	   46	  (48.4)	   950	  [115	  -­‐	  1000]	   95	  [12	  -­‐	  100]	   12	  (26.1)	   27	  (58.7)	   7	  (15.2)	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Iodine	  (µg)	   23	  (24.2)	   150	  [75	  -­‐	  150]	   100	  [50	  -­‐	  100]	   1	  (4.3)	   20	  (87.0)	   2	  (8.7)	  Zinc	  (mg)	   63	  (66.3)	   10	  [7.5	  -­‐	  15]	   100	  [75	  -­‐	  150]	   3	  (4.8)	   38	  (60.3)	   22	  (34.9)	  Manganese	  (mg)	   45	  (47.4)	   2.0	  [1.0	  -­‐	  3.3]	   100	  [50	  -­‐	  165]	   3	  (6.7)	   29	  (64.4)	   13	  (28.9)	  Selenium	  (µg)	   38	  (40.0)	   50	  [27.3	  -­‐	  70]	   91	  [50	  -­‐	  127]	   1	  (2.6)	   28	  (73.7)	   9	  (23.7)	  Chrome	  (µg)	   21	  (22.1)	   35	  [25	  -­‐	  50]	   88	  [63	  -­‐	  125]	   -­‐	   18	  (85.7)	   3	  (14.3)	  Molybdenum	  (µg)	   22	  (23.2)	   50	  [45	  -­‐	  100]	   100	  [90	  -­‐	  200]	   -­‐	   15	  (68.2)	   7	  (31.8)	  Fluoride	  (mg)	   3	  (3.2)	   1.5	  [0.4	  -­‐	  3.5]	   	   	   	   	  Potassium	  (mg)	   21	  (22.1)	   80	  [28	  -­‐	  190]	   4	  [1	  -­‐	  10]	   16	  (76.2)	   4	  (19.1)	   1	  (4.8)	  Phosphorous	  (mg)	   17	  (17.9)	   125	  [20	  -­‐	  142]	   18	  [3	  -­‐	  20]	   8	  (47.1)	   9	  (52.9)	   -­‐	  	  For	  components	  containing	  at	  least	  5	  vitamins	  or	  minerals	  (N=95).	  IQR,	  interquartile	  range;	  MVM,	  multivitamin/multimineral;	  RDA,	  recommended	  dietary	  allowance	  according	  to	  the	  Swiss	  legislation.	  Results	  are	  expressed	  as	  number	  of	  products	  (percentage)	  or	  as	  median	  [interquartile	  range].	  §	  for	  maximum	  recommended	  posology;	  when	  the	  posology	  was	  not	  available,	  a	  value	  of	  1unit/day	  was	  considered.	  No	  RDA	  available	  for	  fluoride	  
	  	   11	  
	  
Table	  2:	  Characteristics	  of,	  and	  vitamin/mineral	  provision	  by	  multivitamin-­‐multimineral	  supplements	  available	  in	  Switzerland.	  




%	  RDA	  §	  
Median	  [IQR]	  
<15%	  RDA	   15-­150%	  
RDA	  
>150%	  RDA	  
Vitamins	   	   	   	   	   	   	  Vitamin	  A	  (IE)	   29	  (63.0)	   2667	  [1739	  -­‐	  3550]	   100	  [50	  -­‐	  131]	   1	  (3.5)	   28	  (96.6)	   -­‐	  Vitamin	  B1	  (mg)	   44	  (95.7)	   1.5	  [1.4	  -­‐	  4.2]	   136	  [127	  -­‐	  377]	   -­‐	   27	  (61.4)	   17	  (38.6)	  Vitamin	  B12	  (µg)	   42	  (91.3)	   3.5	  [2.0	  -­‐	  8.1]	   140	  [78	  -­‐	  325]	   -­‐	   21	  (50.0)	   21	  (50.0)	  Vitamin	  B2	  (mg)	   44	  (95.7)	   1.7	  [1.5	  -­‐	  4.1]	   121	  [104	  -­‐	  293]	   -­‐	   28	  (63.6)	   16	  (36.4)	  Vitamin	  B6	  (mg)	   46	  (100.0)	   2.6	  [2.0	  -­‐	  5.2]	   186	  [143	  -­‐	  368]	   -­‐	   22	  (47.8)	   24	  (52.2)	  Vitamin	  C	  (mg)	   44	  (95.7)	   90	  [60	  -­‐	  180]	   112.5	  [75	  -­‐	  225]	   -­‐	   28	  (63.6)	   16	  (36.4)	  Vitamin	  D	  (µg)	   39	  (84.8)	   5.5	  [5.0	  -­‐	  12.5]	   110	  [100	  -­‐	  250]	   -­‐	   20	  (51.3)	   19	  (48.7)	  Vitamin	  E	  (mg)	   41	  (89.1)	   15	  [10.0	  -­‐	  36.7]	   125	  [83	  -­‐	  305]	   -­‐	   22	  (53.7)	   19	  (46.3)	  Vitamin	  K	  (µg)	   15	  (32.6)	   50	  [25	  -­‐	  75]	   67	  [33	  -­‐	  100]	   -­‐	   14	  (93.3)	   1	  (6.7)	  Niacin	  (mg)	   44	  (95.7)	   18	  [16	  -­‐	  30]	   113	  [100	  -­‐	  188]	   -­‐	   31	  (70.5)	   13	  (29.6)	  Pantothenic	  acid	  (mg)	   38	  (82.6)	   10	  [6	  -­‐	  20]	   167	  [100	  -­‐	  333]	   -­‐	   16	  (42.1)	   22	  (57.9)	  Folic	  acid	  (µg)	   41	  (89.1)	   400	  [200	  -­‐	  407]	   200	  [100	  -­‐	  204]	   -­‐	   14	  (34.2)	   27	  (65.9)	  Biotin	  (µg)	   39	  (84.8)	   75	  [40	  -­‐	  200]	   150	  [80	  -­‐	  400]	   -­‐	   18	  (46.2)	   21	  (53.9)	  
Minerals	   	   	   	   	   	   	  Calcium	  (mg)	   33	  (71.4)	   180.6	  [100	  -­‐	  239]	   23	  [13	  -­‐	  30]	   9	  (27.3)	   24	  (72.7)	   -­‐	  Magnesium	  (mg)	   35	  (76.1)	   60	  [40	  -­‐	  100]	   16	  [11	  -­‐	  27]	   17	  (48.6)	   18	  (51.4)	   -­‐	  Iron	  (mg)	   30	  (65.2)	   10	  [7	  -­‐	  15]	   71	  [50	  -­‐	  107]	   2	  (6.7)	   24	  (80.0)	   4	  (13.3)	  Copper	  (µg)	   30	  (65.2)	   900	  [367.5	  -­‐	  1000]	   90	  [37	  -­‐	  100]	   7	  (23.3)	   20	  (66.7)	   3	  (10.0)	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Iodine	  (µg)	   22	  (47.8)	   150	  [71.3	  -­‐	  150]	   100	  [48	  -­‐	  100]	   1	  (4.6)	   19	  (86.4)	   2	  (9.1)	  Zinc	  (mg)	   41	  (89.1)	   10	  [6.8	  -­‐	  15]	   100	  [68	  -­‐	  150]	   3	  (7.3)	   27	  (65.9)	   11	  (26.8)	  Manganese	  (mg)	   31	  (67.4)	   2	  [1	  -­‐	  3]	   100	  [50	  -­‐	  150]	   2	  (6.5)	   21	  (67.7)	   8	  (25.8)	  Selenium	  (µg)	   25	  (54.4)	   50	  [26.5	  -­‐	  57.5]	   91	  [48	  -­‐	  105]	   1	  (4.0)	   19	  (76.0)	   5	  (20.0)	  Chrome	  (µg)	   19	  (41.3)	   35	  [25	  -­‐	  50]	   88	  [63	  -­‐	  125]	   -­‐	   16	  (84.2)	   3	  (15.8)	  Molybdenum	  (µg)	   21	  (45.7)	   50	  [45	  -­‐	  100]	   100	  [90	  -­‐	  200]	   -­‐	   14	  (66.7)	   7	  (33.3)	  Fluoride	  (mg)	   3	  (6.5)	   1.5	  [0.4	  -­‐	  3.5]	   	   	   	   	  Potassium	  (mg)	   12	  (26.1)	   80	  [22	  -­‐	  80]	   4	  [1	  -­‐	  4]	   11	  (91.7)	   1	  (8.3)	   -­‐	  Phosphorous	  (mg)	   15	  (32.6)	   50	  [20	  -­‐	  133.3]	   7	  [3	  -­‐	  19]	   8	  (53.3)	   7	  (46.7)	   -­‐	  	   For	   components	   containing	   at	   least	   10	   vitamins	   or	   minerals	   (N=46).	   IQR,	   interquartile	   range;	   MVM,	   multivitamin/multimineral;	   RDA,	  recommended	   dietary	   allowance	   according	   to	   the	   Swiss	   legislation.	   Results	   are	   expressed	   as	   number	   of	   products	   (percentage)	   or	   as	   median	  [interquartile	  range].	  §	  for	  maximum	  recommended	  posology;	  when	  the	  posology	  was	  not	  available,	  a	  value	  of	  1/day	  was	  considered.	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Discussion	  To	   our	   knowledge,	   this	   is	   the	   first	   study	   in	   Switzerland	   and	   in	   Europe	   to	   assess	   the	  composition	   and	   compliance	   to	   legislation	   of	  MVM.	  Our	   results	   show	   that	   the	   composition	   of	  MVMs	  varies	  considerably	  according	  to	  the	  definition	  applied.	  For	  instance,	  if	  a	  loose	  definition	  is	  used	  (at	  least	  5	  vitamins	  or	  minerals),	  a	  sizable	  fraction	  of	  the	  MVMs	  lacks	  specific	  vitamins	  or	  minerals;	  using	  a	  more	  restrictive	  criterion	  (at	  least	  10	  vitamins	  or	  minerals)	  leads	  to	  products	  that	   contain	   mostly	   all	   vitamins	   and	   minerals	   of	   interest.	   Hence,	   we	   propose	   that	   MVMs	   be	  defined	  as	  components	  that	  contain	  at	  least	  10	  different	  vitamins	  or	  minerals,	  as	  a	  first	  step	  for	  standardization	   and	   comparison	   between	   studies.	   Conversely,	   the	   amount	   of	   vitamins	   and	  minerals	  per	  unit	  varied	  considerably	  between	  MVMs.	  This	  precludes	  the	  possibility	  of	  devising	  a	   “standard	  MVM”,	   the	   composition	  of	  which	   could	  be	  used	  when	  no	   information	   is	   available	  regarding	   the	   brand	   of	   the	   product	   consumed.	   Thus,	   and	   unless	   new	   legislations	   lead	   to	   a	  narrowing	   of	   the	   amounts	   of	   vitamins	   and	   minerals	   per	   unit,	   the	   use	   of	   a	   “standard	   MVM”	  cannot	  be	  recommended.	  
Amount	  of	  vitamins	  and	  minerals	  provided	  by	  the	  MVMs	  
Slightly	  more	  than	  half	  of	  all	  MVMs	  provided	  vitamins	  in	  amounts	  exceeding	  150%	  of	  the	  RDA,	   while	   the	   percentage	   of	   MVMs	   providing	   minerals	   exceeding	   the	   150%	   threshold	   was	  considerably	   lower.	   Interestingly,	   MVMs	   with	   at	   least	   10	   vitamins	   and	   minerals	   appear	   to	  contain	   lower	   doses	   than	  MVMs	  with	   at	   least	   5	   vitamins	   or	  minerals.	   The	   reasons	   for	   such	   a	  discrepancy	  are	  unclear	  and	  can	  only	  be	  speculated.	  Hydrosoluble	  vitamins	  consumed	  in	  excess	  can	  be	  excreted	  via	   the	   liver,	  while	  no	  such	  mechanism	   is	  available	   for	  some	  minerals;	  hence,	  the	   amount	   of	   minerals	   might	   be	   reduced	   for	   safety	   reasons.	   MVMs	   with	   a	   large	   number	   of	  vitamins	  and	  minerals	  might	  be	  more	  expensive,	  thus	  tempting	  the	  manufacturers	  to	  reduce	  the	  amount	  of	  vitamins	  and	  minerals	  present	  per	  unit.	  Still,	  further	  research	  is	  needed	  to	  clarify	  this	  issue.	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The	   main	   iodine	   source	   in	   Switzerland	   is	   iodized	   table	   salt,	   which	   has	   proved	   a	  successful	   preventive	   measure	   against	   goiter	   and	   iodine	   deficiency	   [8,	   9].	   Still,	  recommendations	   towards	   lower	  salt	   intake	   [10]	  and	   the	  use	  of	   fashionable,	  exotic	   (and	  non-­‐iodized)	  salt	  by	  the	  Swiss	  population	  might	  actually	  lead	  to	  an	  increase	  in	  iodine	  deficiency	  [11].	  Somewhat	  unexpectedly,	  the	  number	  of	  MVMs	  containing	  iodine	  was	  rather	  low,	  while	  it	  could	  be	  of	  benefit	   for	  a	  fraction	  of	  the	  Swiss	  population.	  Indeed,	  MVM	  consumers	  tend	  to	  present	  a	  healthier	  dietary	  pattern	  and	  to	  be	  more	  respondent	  to	  dietary	  recommendations,	  including	  salt	  reduction.	  Hence,	   in	   these	   subjects,	   the	   lower	   iodine	   intake	  due	   to	   lower	   salt	   intake	   could	  be	  compensated	  by	  MVMs.	  
The	  presence	  of	  vitamin	  K	  (mainly	  indicated	  as	  prevention	  against	  arthritis)	  in	  one	  out	  of	  six	  MVMs	  (one	  third	  if	  the	  10	  threshold	  is	  used)	  stresses	  the	  need	  for	  a	  warning.	  Indeed,	  shifting	  from	   one	   MVM	   with	   vitamin	   K	   to	   another	   without	   (and	   vice-­‐versa)	   might	   have	   serious	  consequences	  in	  patients	  on	  anticoagulants	  [12],	  namely	  in	  MVMs	  whose	  content	  of	  vitamin	  K	  exceeds	   150%	   of	   the	   RDA.	   Finally,	   very	   few	   MVMs	   contained	   fluoride,	   probably	   in	   order	   to	  prevent	  any	  adverse	  effect	  of	  excessive	  consumption	  [13].	  
Several	  MVMs	  indicated	  in	  their	  label	  vitamins	  or	  minerals	  in	  amounts	  lower	  than	  15%	  of	  RDA,	  a	  finding	  in	  disagreement	  with	  Swiss	  legislations	  [6].	  Interestingly,	  inadequate	  labelling	  concerned	  calcium,	  magnesium	  and	  copper,	  while	  very	  few	  vitamins	  had	  values	  below	  the	  15%	  level.	   Marketing	   issues	   might	   explain	   this	   finding,	   as	   MVMs	   with	   calcium	   and	   magnesium	  indicated	   in	  the	   label	  might	  be	  more	  appealing	  to	  the	  elderly	  (as	  prevention	  for	  osteoporosis)	  and	  to	  subjects	  with	  anxiety	  [14],	  respectively.	  Still,	  further	  studies	  are	  needed	  to	  better	  assess	  this	  point.	  
Study	  limitations	  
	   This	   study	  has	   several	   limitations	   that	   should	   be	   accounted	   for.	   First,	   the	   collection	   of	  vitamin	  and	  mineral	  supplements	  was	  limited	  to	  the	  canton	  of	  Vaud,	  and	  it	  is	  possible	  that	  other	  products	   are	   available	   in	   other	   cantons.	   Still,	   all	   vitamin	   supplements	   from	   the	   Swiss	   drug	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compendium	   and	   from	   national	   producers	   and	   sellers	   were	   collected,	   which	   might	   limit	   the	  number	  of	  supplements	  missed.	  Second,	  it	  was	  not	  possible	  to	  use	  a	  standard	  definition	  of	  MVM,	  so	   the	   proposed	   ones	   might	   be	   questionable.	   Nevertheless,	   they	   are	   a	   first	   step	   towards	   a	  minimal	  standardisation	  of	  the	  definition	  of	  MVM,	  thus	  allowing	  further	  comparisons	  between	  studies.	  Third,	  it	  was	  not	  possible	  to	  validate	  the	  vitamin	  and	  mineral	  content	  of	  the	  MVM,	  due	  to	   the	   lack	   of	   funding.	   It	   will	   be	   of	   interest	   that	   the	   Swiss	   agency	   for	   therapeutic	   products	  performs	   such	   controls,	   at	   least	   in	   a	   limited	   sample	   of	   MVMs.	   Fourth,	   some	   MVMs	   had	   no	  posology	  indicated,	  and	  a	  maximal	  posology	  of	  one	  unit	  per	  day	  had	  to	  be	  considered.	  Still,	  the	  one	  per	  day	  posology	  is	  the	  most	  frequent	  for	  MVMs.	  Finally,	  we	  used	  the	  RDAs	  indicated	  in	  the	  Swiss	  legislation	  [6]	  instead	  of	  the	  RDAs	  suggested	  by	  the	  Swiss	  Society	  of	  Nutrition	  (SSN)	  [15].	  As	  the	  values	  differ	  (table	  3),	  the	  results	  would	  be	  different	  if	  the	  RDAs	  of	  the	  SSN	  were	  used.	  Still,	  as	  we	  aimed	  at	  assessing	  compliance	  with	  national	  legislations,	  we	  consider	  that	  the	  choice	  of	  the	  RDAs	  from	  the	  legislation	  was	  appropriate.	  
Conclusion	  




Table	  3.	  Comparison	  of	  the	  recommended	  dietary	  allowances	  for	  adults	  from	  the	  Swiss	  legislation	  and	  from	  the	  Swiss	  Society	  of	  Nutrition	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The	  fallacy	  of	  slimming	  products:	  a	  case	  analysis	  in	  Switzerland	  
Abstract	  
Objectives:	  To	  assess	  weight	  loss	  claims	  of	  slimming	  products	  available	  in	  Switzerland	  
Methods:	  Between	  May	  2008	  and	  February	  2013,	  31	  advertisements	  for	  13	  different	  slimming	  products	  from	  a	  single	  seller	  were	  collected	  and	  their	  content	  analyzed.	  
Results:	  Total	  weight	   loss	  claims	  ranged	  between	  7	  and	  31	  kg,	  with	  an	  estimated	  daily	  weight	  loss	   ranging	   between	   300g	   and	   1kg.	   Eighty-­‐four	   percent	   of	   the	   advertisements	   included	   the	  photograph	  of	  a	  woman,	  61%	  showed	  a	  picture	  of	  a	  person	  before	  and	  after	  using	  the	  product,	  and	   51%	   claimed	   that	   the	   product	   had	   improved	   marital	   relationships.	   The	   terms	   “natural”,	  “miracle/extraordinary”	   and	   “scientific”	   were	   present	   in	   92%,	   77%,	   and	   31%	   of	   the	  advertisements,	  respectively.	  Cost	  per	  package	  was	  very	  similar	  for	  all	  13	  products	  (range:	  49	  to	  59	  CHF	  –	  52	  to	  63	  US$,	  with	  8	  products	  costing	  the	  same	  amount)	  and	  no	  correlation	  was	  found	  between	  cost	  of	  the	  product	  and	  weight	   loss	  claims.	  No	  differences	  were	  found	  for	  weight	   loss	  claims	   according	   to	   presence	   or	   absence	   of	   a	   picture	   or	   of	   the	   terms	   “natural”,	  “miracle/extraordinary”	   and	   “scientific”.	   Supposing	   that	   1%	   of	   readers	   bought	   one	   product	  advertised,	   the	   yearly	   revenues	   ranged	   between	   2.35	   and	   6.37	   million	   CHF	   (2.52	   and	   6.83	  million	  US$).	  
Conclusion:	   In	  Switzerland,	  advertisements	  for	  slimming	  products	  use	  positive	  and	  reassuring	  terms	   to	   attract	   consumers,	  which	  are	   lured	  by	  unreachable,	   false	  promises	  of	   rapid	  and	  easy	  weight	  loss.	  The	  revenues	  appear	  to	  be	  considerable.	  Adequate	  implementation	  of	  the	  regulation	  of	  such	  products	  is	  urgently	  needed.	  
	  
Keywords:	  slimming	  products;	  advertisement;	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Introduction	  Obesity	   is	   increasing	  worldwide.	  As	   a	   corollary,	   the	  market	   of	   slimming	  or	   low	   calorie	  products	   has	   evolved	   at	   a	   similar	   if	   not	   a	   higher	   pace.	   It	   has	   been	   estimated	   that	   the	   global	  weight	  management	  market	  will	  attain	  US$586	  billion	  in	  2014	  1,	  a	  value	  higher	  than	  the	  GNP	  of	  Greece	   2.	   In	   the	   US,	   it	   has	   been	   estimated	   that	   15.2%	   of	   adults	   had	   ever	   used	   a	   weight-­‐loss	  supplement	   3.	   In	   a	   competitive	   market	   and	   in	   the	   absence	   of	   strict	   regulations,	   unethical	  marketing	  strategies	  are	  put	  forward	  to	  sell	  slimming	  products	  whose	  properties	  have	  not	  been	  scientifically	  proven	  4.	  Indeed,	  many	  marketing	  strategies	  capitalize	  into	  concepts	  such	  as	  quick	  results,	   obtained	   at	   little	   if	   no	   change	   in	   lifestyle,	   in	   almost	   complete	   disagreement	   with	   the	  scientific	   literature.	  Overweight	  or	  obese	  subjects	  are	   lured	   into	  buying	  products	  of	   little	   if	  no	  proven	  efficacy,	  with	  potential	  effects	   in	   the	  self-­‐esteem	  (incapacity	  of	  achieving	   the	  promised	  weight	  losses)	  and	  anxiety	  of	  these	  subjects	  5.	  This	  leads	  to	  a	  spiral	  of	  disappointment/increased	  expectations/action	  (buying	  a	  “new”	  slimming	  product)	  and	  again	  disappointment,	  which	  could	  significantly	  decrease	  further	  adherence	  to	  adequate	  weight	  loss	  strategies	  6.	  Indeed,	  overweight	  or	   obese	   subjects	   continuously	   submitted	   to	   claims	   of	   quick	   and	   easy	  weight	   losses	   by	   these	  marketing	  strategies	  will	  be	  less	  prone	  in	  adhering	  to	  weight	  loss	  strategies	  that	  must	  be	  applied	  for	   a	   long	   time	   and	   that	   rely	   on	   lifestyle	   changes	   7.	   Still,	   to	   the	   best	   of	   our	   knowledge,	   little	  objective	  data	  has	  been	  published	  on	  the	  marketing	  strategies	  of	  slimming	  products	  with	  little	  if	  no	  proven	  efficacy.	  
Thus,	  we	  performed	  a	  qualitative	  analysis	  of	  the	  weight	  loss	  claims	  of	  several	  slimming	  products	  available	  in	  Switzerland.	  We	  conducted	  the	  study	  by	  analyzing	  the	  publicities	  for	  these	  products	  as	  they	  appeared	  in	  the	  most	  read	  Swiss	  magazine.	  
Methods	  	   Between	  May	  2008	  and	  February	  2013,	  31	  advertisements	  for	  13	  different	  slimming	  products	  appearing	  in	  the	  largest	  Swiss	  magazine	  were	  analyzed.	  This	  magazine	  appears	  every	  two	  weeks	  and	  claims	  over	  1.2	  million	  readers	  per	  issue,	  corresponding	  to	  almost	  one	  fifth	  of	  the	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Swiss	  adult	  population.	  The	  magazine	  is	  issued	  in	  the	  three	  official	  languages	  of	  Switzerland	  (German,	  French	  and	  Italian),	  but	  only	  the	  advertisements	  in	  the	  French-­‐speaking	  issues	  were	  collected.	  A	  further	  analysis	  of	  the	  other	  issues	  showed	  that	  the	  advertisements	  actually	  appeared	  in	  all	  language	  editions,	  and	  that	  the	  text	  was	  similar	  (not	  show).	  
Data	  extraction	  
For	  each	  advertisement,	  we	  conducted	  a	  text	  analysis	  searching	  for	  the	  words	  related	  to	  evidence	   based	   data	   (“science	   /	   scientific”;	   ”trial	   /	   study”)	   or	   not	   (“miracle	   /	   wonderful	   /	  marvellous”;	   “secret	   /	   hidden”).	   The	   characteristics	   of	   the	   weight	   loss	   were	   categorized	   by	  searching	  words	  such	  as	  “quick”,	  “easy”,	  “no	  change”	  (in	  lifestyle)	  and	  by	  collecting	  the	  promised	  weight	  loss	  (number	  of	  kg	  and	  duration	  of	  weight	  loss	  period).	  The	  characteristics	  of	  the	  product	  were	   categorized	   by	   searching	   words	   such	   as	   “natural”	   or	   “bio”	   and	   by	   assessing,	   whenever	  possible,	  its	  origin	  (plant	  extract	  or	  other).	  Personal	  and	  social	  benefits	  of	  the	  weight	  loss	  were	  evaluated	   by	   searching	   situations	   such	   as	   recovering	   self-­‐esteem,	   recovering	   the	   love	   from	  family	  or	  obtaining	  a	  job	  position.	  Other	  data,	  such	  as	  the	  presence	  of	  a	  before/after	  picture,	  the	  gender	  of	  the	  person	  in	  the	  picture	  (male/female),	  the	  presence	  of	  a	  promotional	  gift	  were	  also	  collected.	  
Market	  value	  
It	  was	  not	  possible	   to	  assess	  directly	   the	   true	  returns	   for	   the	  selling	  of	   these	  products;	  hence,	  we	  calculated	  the	  overall	  yearly	  costs	  for	  their	  advertisements	  based	  on	  the	  advertising	  costs	  for	  2012	  as	  indicated	  by	  the	  magazine.	  As	  publicity	  usually	  leads	  to	  higher	  returns	  than	  the	  initial	  costs	  of	  advertising,	  it	  was	  expected	  that	  the	  true	  sales	  would	  at	  least	  exceed	  the	  expenses	  in	   publicity.	   A	   second	   estimation	   was	   performed,	   by	   collecting	   the	   cost	   of	   the	   product	   and	  supposing	   that	  1%	  of	   the	  readers	  of	   the	  magazine	  would	  buy	  one	  unit	  of	   the	  product	   for	  each	  advertisement.	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As	  this	  information	  is	  freely	  available,	  no	  specific	  authorizations	  from	  commercial	  firms	  or	  from	  Ethics	  Committees	  were	  needed.	  
Statistical	  analyses	  
Data	   was	   inserted	   in	   an	   Excel	   (Microsoft,	   Redmond,	   USA)	   spreadsheet	   and	   further	  analyzed	   using	   Stata	   v.	   12.0	   (Stata	   corp,	   College	   Station,	   TX,	   USA).	   Descriptive	   results	   were	  expressed	   as	   number	   of	   advertisements	   and	   (percentage)	   or	   as	   range.	   Comparisons	   were	  performed	  using	  Fisher’s	  exact	   test	   for	  qualitative	  data	  and	  Kruskal-­‐Wallis	  nonparametric	   test	  for	  quantitative	  data.	  
Results	  	   Between	  2008	  and	  2012,	   thirty-­‐one	  advertisements	   for	  13	  different	  slimming	  products	  appeared	   in	   the	   French	   issue	   of	   the	   magazine.	   As	   the	   advertisements	   for	   a	   given	   product	  appeared	  several	  times,	  the	  analysis	  was	  based	  on	  the	  13	  different	  products.	  
The	  terms	  “natural”,	  “miracle/extraordinary”	  and	  “scientific”	  were	  present	  in	  92%,	  77%,	  and	  31%	  of	  the	  products,	  respectively.	  The	  promises	  of	  weight	  loss	  ranged	  between	  7	  and	  31	  kg	  within	   a	   period	   of	   time	   ranging	   between	   7	   days	   to	   7	  weeks.	   The	   estimated	   daily	  weight	   loss	  ranged	   between	   300g	   and	   1	   kg.	   Almost	   all	   (94%)	   of	   the	   advertisements	   targeted	   women	   by	  including	  the	  photograph	  of	  a	  woman;	  61%	  showed	  a	  picture	  of	  a	  person	  before	  and	  after	  using	  the	  product,	   and	  51%	  claimed	   that	   the	  product	  had	   improved	  marital	   relationships.	  Free	  gifts	  were	  provided	  to	  buyers	  for	  69%	  of	  the	  products.	  
Cost	  was	   very	   similar	   for	   all	   13	  products	   (range:	   49	   to	   59	  CHF	   -­‐	   52	   to	   63	  US$,	  with	   8	  products	  costing	  the	  same	  amount)	  and	  no	  correlation	  was	   found	  between	  cost	  of	   the	  product	  and	  weight	  loss	  claims	  (spearman	  correlation	  between	  minimal	  cost	  and	  total	  weight	  loss:	  -­‐0.41,	  p=0.16;	  between	  minimal	  cost	  and	  weight	  loss	  rate:	  0.28,	  p=0.41).	  No	  differences	  were	  found	  for	  weight	   loss	   claims	   according	   to	   presence	   or	   absence	   of	   a	   picture	   or	   of	   the	   terms	   “natural”,	  “miracle/extraordinary”	  and	  “scientific”	  (all	  p>0.05,	  not	  shown).	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The	  yearly	  costs	  for	  advertising	  such	  products	  ranged	  between	  56,000	  and	  126,000	  CHF	  (60,000	   to	  135,000	  US$)	   for	   French-­‐speaking	   Switzerland,	   and	  between	  190,000	   and	  428,000	  CHF	   (204,000	   to	   459,000	  US$)	   for	  whole	   Switzerland.	   Considering	   that	   1%	   of	   the	   1.2	  million	  readers	  actually	  bought	  one	  unit	  of	  the	  product,	  the	  estimated	  annual	  revenues	  ranged	  between	  2.35	  and	  6.37	  million	  CHF	  (2.52	  and	  6.83	  million	  US$).	  
Discussion	  	  There	   are	   few	   if	   any	   studies	   on	   the	   content	   of	   advertisements	   for	   slimming	   products	  marketed	  in	  Switzerland	  or	  in	  Europe.	  A	  similar	  study	  conducted	  in	  the	  early	  nineties	  in	  France	  concluded	   that	  most	   advertisements	   for	   slimming	   products	   do	   not	   give	   any	   indication	   on	   the	  composition	   of	   products	   or	   on	   the	   nature	   of	   the	   proposed	   methods,	   and	   that	   the	   selling	  arguments	  are	  most	  often	  fallacious	  4.	  Indeed,	  the	  arguments	  of	  the	  advertisements	  for	  slimming	  products	  in	  1992	  differed	  little	  from	  the	  ones	  collected	  in	  our	  study,	  suggesting	  that	  the	  general	  public	  is	  still	  receptive	  to	  them.	  Further,	  the	  weight	  loss	  claims	  are	  several	  orders	  of	  magnitude	  higher	   than	   achieved	   by	   adequately	   conducted	   randomized	   controlled	   trials	   8,	   9,	   which	   raises	  ethical	  10	  and	  even	  legal	  issues	  11,	  as	  they	  lure	  vulnerable	  obese	  people	  into	  falsely	  believing	  that	  weight	  loss	  can	  be	  easily	  achieved	  without	  any	  change	  in	  lifestyle.	  	  
Interestingly,	   the	  EU	  (non-­‐Swiss)	   legislation	  on	  slimming	  products	  relates	  to	  foods	  that	  replace	  the	  whole	  or	  part	  of	  the	  total	  daily	  diet	  12,	  while	  most	  if	  not	  all	  products	  analysed	  here	  were	   considered	   as	   supplements,	   hence	   not	   encompassed	   strictu	   sensu	   by	   the	   legislation.	  Our	  results	  thus	  suggest	  that	  some	  companies	  consistently	  exploit	  legislative	  voids	  to	  use	  fallacious	  arguments	   which	   would	   be	   forbidden,	   had	   their	   products	   be	   commercialized	   as	   dietary	  replacements.	   More	  worryingly,	   Switzerland	   has	   a	   specific	   regulation	   regarding	   the	   slimming	  properties	   of	   dietary	   products	   (ODAlOUs),	   which	   prohibits	   any	   kind	   of	   endorsement	   for	  foodstuffs	   as	   a	  weight	   loss	  product,	   or	   suggesting	   that	   it	   has	   similar	  properties	   (article	  10)	   13.	  The	   fact	   that	   several	   companies	   manage	   to	   promote	   and	   sell	   such	   kind	   of	   products	   in	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Switzerland	   further	   stresses	   the	   need	   of	   adequately	   enforcement	   of	   the	   existing	   regulations,	  rather	  the	  issuing	  of	  new	  ones.	  
	  This	  study	  has	  some	  limits.	  First,	  we	  only	  searched	  a	  single	  magazine,	  and	  it	  might	  not	  be	  representative	  of	  the	  other	  magazines	  read	  by	  the	  Swiss	  general	  population.	  Still,	  this	  is	  by	  far	  the	   most	   read	   magazine	   in	   Switzerland,	   and	   a	   further	   search	   on	   other	   public	   magazines	  (including	   one	   distributed	   in	   pharmacies	   at	   400,000	   copies/month)	   showed	   the	   same	   type	   of	  advertisements.	  Hence,	  we	  do	  believe	   that	   this	   sort	  of	   advertisement	   is	   rather	   common	   in	   the	  Swiss	   public	   press.	   Second,	   we	   could	   only	   provide	   a	   rough	   estimate	   of	   the	   potential	   income	  generated	  by	  such	  products.	  Although	  the	  cost/effectiveness	  and	  impact	  of	  such	  advertisements	  on	  the	  knowledge	  on	  weight	  reduction	  by	  the	  general	  population	  is	  unknown,	  it	  is	  most	  certainly	  higher	   than	   the	   impact	   of	   the	   preventive	   campaigns	   on	   healthy	   body	   weight	   conducted	   in	  Switzerland.	  For	  instance,	  in	  2011,	  14.8	  million	  CHF	  (15.9	  million	  US$)	  were	  invested	  in	  healthy	  body	  weight	   promotion	   campaigns,	  which	   impacted	   130,000	   children	   and	   adolescents	   and	   an	  unknown	  number	  of	   adults	   14.	   This	   is	   roughly	  one	   tenth	   the	  number	  of	   subjects	   and	  40	   times	  more	  expensive	  than	  what	  was	  achieved	  via	  advertisements	  in	  the	  Swiss	  magazine	  studied,	  and	  even	  lower	  (resp.	  higher)	  if	  other	  magazines	  were	  taken	  into	  account.	  Our	  results	  thus	  suggest	  that,	  in	  Switzerland,	  the	  marketing	  of	  (ineffective)	  slimming	  products	  is	  considerably	  more	  cost-­‐effective	   than	   healthy	   body	   weight	   promotion.	   Our	   results	   also	   suggest	   the	   revenues	   are	  considerable,	   even	   when	   a	   conservative	   estimate	   that	   only	   1%	   of	   the	   readers	   (compared	   to	  much	  higher	  values	  observed	  in	  the	  United	  States	  3)	  buy	  one	  single	  unit	  of	  the	  product.	  
We	  conclude	  that	  in	  Switzerland,	  advertisements	  for	  slimming	  products	  use	  positive	  and	  reassuring	  terms	  to	  attract	  consumers,	  which	  are	  lured	  by	  unreachable,	  false	  promises	  of	  rapid	  and	   easy	  weight	   loss.	   The	   revenues	   obtained	   are	   considerable,	   possibly	   amounting	   to	   several	  million	   per	   year.	   Adequate	   implementation	   of	   the	   regulation	   of	   such	   products	   is	   urgently	  needed.	  
	  	  
26	  
References	  1.	   Markets	  and	  Markets.	  Global	  weight	  loss	  and	  diet	  management	  market	  (2009	  -­‐	  2014)	  Wilmington,	  DE,	  USA2009.	  2.	   Central	  Intelligence	  Agency.	  CIA	  World	  Factbook:	  Greece.	  2014.	  3.	   Blanck	  HM,	  Serdula	  MK,	  Gillespie	  C,	  et	  al.	  Use	  of	  nonprescription	  dietary	  supplements	  for	  weight	  loss	  is	  common	  among	  Americans.	  J	  Am	  Diet	  Assoc.	  2007;	  107:	  441-­‐7.	  4.	   Debry	  G	  and	  Debry	  A.	  [Advertisements	  for	  the	  treatment	  of	  obesity	  or	  deceit	  without	  limits].	  
Bull	  Acad	  Natl	  Med.	  1992;	  176:	  497-­‐506;	  discussion	  -­‐10.	  5.	   Utter	  J,	  Neumark-­‐Sztainer	  D,	  Wall	  M	  and	  Story	  M.	  Reading	  magazine	  articles	  about	  dieting	  and	  associated	  weight	  control	  behaviors	  among	  adolescents.	  J	  Adolesc	  Health.	  2003;	  32:	  78-­‐82.	  6.	   Cereda	  E,	  Malavazos	  AE,	  Caccialanza	  R,	  Rondanelli	  M,	  Fatati	  G	  and	  Barichella	  M.	  Weight	  cycling	  is	  associated	  with	  body	  weight	  excess	  and	  abdominal	  fat	  accumulation:	  a	  cross-­‐sectional	  study.	  Clin	  Nutr.	  2011;	  30:	  718-­‐23.	  7.	   Field	  AE,	  Cheung	  L,	  Wolf	  AM,	  Herzog	  DB,	  Gortmaker	  SL	  and	  Colditz	  GA.	  Exposure	  to	  the	  mass	  media	  and	  weight	  concerns	  among	  girls.	  Pediatrics.	  1999;	  103:	  E36.	  8.	   Appel	  LJ,	  Clark	  JM,	  Yeh	  HC,	  et	  al.	  Comparative	  effectiveness	  of	  weight-­‐loss	  interventions	  in	  clinical	  practice.	  N	  Engl	  J	  Med.	  2011;	  365:	  1959-­‐68.	  9.	   Wadden	  TA,	  Volger	  S,	  Sarwer	  DB,	  et	  al.	  A	  two-­‐year	  randomized	  trial	  of	  obesity	  treatment	  in	  primary	  care	  practice.	  N	  Engl	  J	  Med.	  2011;	  365:	  1969-­‐79.	  10.	   de	  Beaufort	  I	  and	  Vandamme	  S.	  'No	  willpower	  required'.	  The	  slimming	  industry	  and	  the	  right	  to	  sell	  dreams.	  Med	  Law.	  2008;	  27:	  215-­‐28.	  11.	   Candlish	  J.	  The	  legality	  of	  slimming	  advertisements	  in	  Singapore.	  Med	  Law.	  1999;	  18:	  567-­‐75.	  12.	   On	  foods	  intended	  for	  use	  in	  energe-­‐restricted	  diets	  for	  weight	  reduction.	  In:	  Commission	  EE,	  (ed.).	  Commission	  directive	  96/8/EC.	  Official	  Journal	  of	  the	  European	  Communities,	  1996,	  p.	  4.	  
	  	   27	  
13.	   Conseil	  Fédéral	  Suisse.	  ODAlOUs	  -­‐	  Ordonnance	  sur	  les	  denrées	  alimentaires	  et	  les	  objets	  usuels.	  In:	  Federal	  Office	  of	  Public	  Health,	  (ed.).	  RS	  81702.	  Bern,	  Switzerland2005,	  p.	  44.	  14.	   Fässler	  S,	  Laubereau	  B,	  Morier	  C,	  Wight	  N	  and	  Balthasar	  A.	  Synthèse	  2012	  de	  l’autoévaluation	  des	  programmes	  d’action	  cantonaux	  «poids	  corporel	  sain».	  Bern	  &	  Lausanne,	  Switzerland:	  Promotion	  Santé	  Suisse,	  ,	  2013,	  p.	  41.	  
	   	  
